ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Merck & Co. is investing $35 million in a new investment fund, the Merck Lumira Biosciences Fund, that’s intended to support early life sciences innovation in Quebec. Other investors in the fund, which hopes to raise $50 million in all, include Lumira Capital and Teralys Capital. Merck’s contribution is part of the $100 million it promised in 2010 to invest in Quebec life sciences R&D when it announced its decision to close the Merck Frosst Centre for Therapeutic Research in Montreal.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter